Recursion Provides Business Updates and Reports Fourth
Initiated five clinical trials in 2022, including three Phase 2 programs, and provided guidance on the timing of clinical data readoutsDelivered against...
Salt Lake City United States Chris Gibson Development Expenses Recursion Pharmaceuticals Inc Chemical Technology
Source: globenewswire.com